Bubble or no bubble, this is the best stock for AI exposure: analyst
LONDON - Investment manager BlackRock, Inc. has increased its stake in CVS Group PLC to 5.07%, according to a regulatory filing disclosed Friday.
The threshold was crossed on November 20, with BlackRock now holding voting rights attached to 3,562,882 shares, representing 5.00% of the veterinary services company. An additional 53,623 voting rights, or 0.07%, are held through financial instruments in the form of securities lending arrangements.
The filing shows BlackRock’s previous position stood at 5.02%, with 4.81% in direct voting rights and 0.20% through financial instruments.
The notification, submitted under the UK’s Disclosure Guidance and Transparency Rules, details the full chain of BlackRock’s controlled undertakings through which the voting rights and financial instruments are held.
CVS Group operates veterinary practices, diagnostic laboratories, and pet crematoria across the UK, Ireland, and the Netherlands.
The information was disclosed in a standard form for notification of major holdings submitted to the London Stock Exchange.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
